XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 68,600 $ 96,952
Marketable securities 251,482 267,690
Accounts receivable 21,380 28,082
Prepaid expenses 15,112 13,900
Other current assets 22,235 9,352
Total current assets 378,809 415,976
Marketable securities 95,302 200,560
Accounts receivable, net 1,143 1,504
Property and equipment, net 138,680 141,685
Operating lease right-of-use assets 62,436 65,116
Restricted cash 2,255 2,030
Other assets 3,833 6,397
Total assets 682,458 833,268
Current liabilities    
Accounts payable 11,639 27,213
Accrued expenses and other current liabilities 50,517 46,794
Deferred revenue 448 1,829
Operating lease liabilities 6,326 5,997
Liability related to sale of future royalties 48,963 48,601
Total current liabilities 117,893 130,434
Operating lease liabilities 85,254 88,802
Liability related to sale of future royalties 67,377 89,005
Other liabilities 6,079 8,832
Total liabilities 276,603 317,073
Stockholders’ equity    
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at June 30, 2023 and December 31, 2022
Common stock; $0.0001 par value; 100,000 shares authorized at June 30, 2023 and December 31, 2022; 43,621 and 43,299 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 4 4
Additional paid-in capital 996,239 973,145
Accumulated other comprehensive loss (10,098) (15,401)
Accumulated deficit (580,290) (441,553)
Total stockholders’ equity 405,855 516,195
Total liabilities and stockholders’ equity $ 682,458 $ 833,268